Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2004-08-24
2009-11-10
Tsang, Cecilia (Department: 1654)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S134100, C424S143100, C514S015800
Reexamination Certificate
active
07615210
ABSTRACT:
A method of combating menorrhagia, dysmenorrhoea or endometriosis in a female individual that includes administering to the individual at least one agent that reduces the effect of prokineticin 1 on a prokineticin receptor.
REFERENCES:
patent: 6121230 (2000-09-01), Charnock-Jones et al.
patent: 7005418 (2006-02-01), Riethmuller-Winzen et al.
patent: 2002/0192634 (2002-12-01), Ferrara et al.
patent: 2003/0059856 (2003-03-01), Ames, Jr. et al.
patent: 2003/0099971 (2003-05-01), Ni et al.
patent: 2003/0113867 (2003-06-01), Zhou et al.
patent: 2003/204933 (2004-01-01), None
patent: 1386615 (2004-02-01), None
patent: 2004-043468 (2004-02-01), None
patent: WO 94/10202 (1994-11-01), None
patent: WO 02/00711 (2002-01-01), None
patent: WO 03/020892 (2003-03-01), None
Pelvic Mass in the Merck Manual.
Endometriosis in the Merck Manual.
Pelvic Mass in the Merck Manual, pp. 1-2. Accessed Apr. 19, 2007.
Endometriosis in the Merck Manual, pp. 1-4. Accessed Mar. 13, 2007.
Bartel & Szostak, “Isolation of New Ribozymes from a Large Pool of Random Sequences,”Science261:1411-1418 (1993).
Coombes et al., “Idoxifene: Report of a Phase I Study in Patients with Metastatic Breast Cancer,”Cancer Res.55:1070-1074 (1995).
Derossi et al., “Trojan Peptides: The Penetratin System for Intracellular Delivery,”Trends Cell Biol.8:84-87 (1998).
Genbank Accession No. AAM48127 (Jun. 6, 2002).
Genbank Accession No. AAM48128 (Jun. 6, 2002).
Genbank Accession No. AF506287 (Jun. 6, 2002).
Genbank Accession No. AF506288 (Jun. 6, 2002).
Genbank Accession No. NM—032414 (Apr. 6, 2003).
Genbank Accession No. NP—068754 (Apr. 6, 2003).
Genbank Accession No. NP—115790 (Apr. 6, 2003).
Genbank Accession No. Q9HC23 (Sep. 15, 2003).
Harper-Wynne & Coombes, “Anastrozole Shows Evidence of Activity in Postmenopausal Patient Who Have Responded or Stabilised on Formestane Therapy,”Eur. J. Cancer35:744-746 (1999).
Labrie et al., “EM-652 (SCH57068), a Pure SERM Having Complete Antiestrogenic Activity in the Mammary Gland and Endometrium,”J. Steroid Biochem. Mol. Biol.79:213-225 (2001).
LeCouter et al., “Identification of an Angiogenic Mitogen Selective for Endocrine Gland Endothelium”Nature412:877-884 (2001).
LeCouter et al., “The Endocrine-Gland-Derived VEGF Homologue Bv8 Promotes Angiogenesis in the Testis: Localization of Bv8 Receptors to Endothelial Cells,”Proc. Natl. Acad. Sci. USA100:2685-2690 (2003).
Li et al., “Identification of Two Prokineticin cDNAs: Recombinant Proteins Potently Contract Gastrointestinal Smooth Muscle,”Mol. Pharmacol.59(4):692-698 (2001).
Lin et al., “Identification and Molecular Characterization of Two Closely Related G Protein-Coupled Receptors Activated by Prokineticins/Endocrine Gland Vascular Endothelial Growth Factor,”J. Biol. Chem.277(22):19276-19280 (2002).
Lin et al., “Characterization of Endocrine Gland-Derived Vascular Endothelial Growth Factor Signaling in Adrenal Cortex Capillary Endothelial Cells,”Biol. Chem.277(10):8724-8729 (2002).
Masuda et al., “Isolation and Identification of EG-VEGF/Prokineticins as Cognate Ligands for Two Orphan G-Protein-Coupled Receptors,”Biochem. Biophys. Res. Comm.293:396-402 (2002).
Noyes et al., “Dating the Endometrial Biopsy,”Am. J. Obstet. Gynecol.122(2):262-263 (1975).
Smith, “Regulation of Angiogenesis in the Endometrium,”TRENDS Endocrinol. Metab.12(4):147-151 (2001).
Soga et al., “Molecular Cloning and Characterization of Prokineticin Receptors,”Biochim. et Biophys. Acta1579:173-179 (2002).
Jabbour Henry Nicolas
Millar Robert Peter
Ha Julia
Medical Research Council
Nixon & Peabody LLP
Tsang Cecilia
LandOfFree
Treatment of endometriosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of endometriosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of endometriosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4104053